首页|血清CYFRA21-1、CA125、CA153、CEA对乳腺癌的诊断及预测术后复发的价值

血清CYFRA21-1、CA125、CA153、CEA对乳腺癌的诊断及预测术后复发的价值

扫码查看
目的 探讨血清C角蛋白19片段抗原21-1(CYFRA21-1)、糖类抗原125(CA125)、糖类抗原153(CA153)、癌胚抗原(CEA)对乳腺癌的诊断及预测术后复发的价值.方法 选取2019年9月至2020年8月在平顶山市第一人民医院诊治的97例乳腺癌患者作为研究组,随访3 a,按照术后有无复发分为复发组19例和未复发组78例,并选取同期健康体检者50例作为对照组,比较研究组与对照组、复发组与未复发组血清CYFRA21-1、CA125、CA153、CEA水平,并分析血清CYFRA21-1、CA125、CA153、CEA对乳腺癌的诊断价值,以及对乳腺癌术后复发的预测价值.结果 研究组血清CYFRA21-1、CA125、CA153、CEA 水平高于对照组(P<0.05).ROC 曲线分析显示,血清 CYFRA21-1、CA125、CA153、CEA、四者联合诊断乳腺癌的AUC分别为0.784、0.722、0.754、0.821、0.888,在最佳临界值对应的敏感度、特异度CA125为 59.8%、100.0%,CA153 为 55.7%、100.0%,CEA 为 58.8%、100.0%,四者联合为 70.4%、100.0%.复发组血清CYFRA21-1、CA125、CA153、CEA 水平高于未复发组(P<0.05).ROC 曲线分析显示,血清 CYFRA21-1、CA125、CA153、CEA预测乳腺癌术后复发的AUC分别0.843、0.862、0.825、0.731、0.914,在最佳临界值对应的敏感度、特异度CA125 为68.4%、100%,CA153 为 73.7%、74.4%,CEA 为 57.9%、88.5%,四者联合为 78.9%、96.2%.结论 血清CYFRA21-1、CA125、CA153、CEA四者联合对乳腺癌诊断和预测术后复发均具有较高的价值.
Diagnostic Value of Serum CYFRA21-1,CA125,CA153 and CEA in the Diagnosis and Prediction of Postoperative Recurrence of Breast Cancer
Objective To explore the diagnostic value of serum C-keratin 19 fragment antigen 21-1(CYFRA21-1),carbohydrate antigen 125(CA125),carbohydrate antigen 153(CA153)and carcinoembryonic antigen(CEA)in the diagnosis and prediction of postoperative recurrence of breast cancer.Methods A total of 97 cases of breast cancer patients diagnosed and treated in Pingdingshan First People's Hospital from September 2019 to August 2020 were selected as the research group,followed up for 3 years,and divided into recurrent group(19 cases)and non-recurrent group(78 cases)according to whether there was recurrence after operation,and 50 healthy people in the same period were selected as the control group.The serum levels of CYFRA21-1,CA125,CA153 and CEA were compared between the research group and the control group,and between the recurrent group and the non-recurrent group,and the serum CYFRA was analyzed.Results Serum CYFRA21-1,CA125,CA153 and CEA in the study group were higher than those in the control group(P<0.05).ROC curve analysis showed that the AUC of serum CYFRA21-1,CA125,CA153,CEA and their combination in the diagnosis of breast cancer were 0.784,0.722,0.754,0.821 and 0.888,respectively,and the sensitivity and specificity at the optimal critical value were CA125 59.8%and 100.0%,CA153 55.37%,100.0%,CEA 58.8%,100.0%,their combination 70.4%,100.0%respectively.Serum CYFRA21-1,CA125,CA153 and CEA in recurrent group were significantly higher than those in non-recurrent group(P<0.05).ROC curve analysis showed that the AUC of serum CYFRA21-1,CA125,CA153 and CEA in predicting postoperative recurrence of breast cancer were 0.843,0.862,0.825,0.731 and 0.914,respectively.At the optimal cut-off value,the sensitivity and specificity were 68.4%and 100%for CA125,73.7%and 74.4%for CA153,57.9%and 88.5%for CEA,and 78.9%and 96.2%for the combination of the four indexes.Conclusion The combination of serum CYFRA21-1,CA125,CA153 and CEA has high diagnostic and predictive value for the diagnosis and postoperative recurrence of breast cancer.

C-keratin 19 fragment antigen 21-1carbohydrate antigen 125carbohydrate antigen 153carcinoembryonic antigenbreast cancerpostoperative recurrence

田二军、王滨、姜楠

展开 >

平顶山市第一人民医院检验科,河南平顶山 467000

C角蛋白19片段抗原21-1 糖类抗原125 糖类抗原153 癌胚抗原 乳腺癌 术后复发

2024

河南医学研究
河南省医学科学院

河南医学研究

影响因子:0.979
ISSN:1004-437X
年,卷(期):2024.33(11)